Blainville-Crevon, France

Laurent Drouot

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ucb Holdings, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent Drouot. Retrieved from https://idiyas.com/inventor/laurent-drouot-so181ba5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurent Drouot

Introduction

Laurent Drouot is a notable inventor based in Blainville-Crevon, France. He has made significant contributions to the field of medical treatments, particularly in the area of inflammatory diseases. His work has led to the development of innovative solutions that aim to improve patient outcomes.

Latest Patents

Drouot holds a patent for "Inflammatory Disease Treatment with Complement Inhibitors." This patent represents a crucial advancement in the treatment of inflammatory conditions, showcasing his commitment to addressing complex medical challenges.

Career Highlights

Currently, Laurent Drouot is associated with UCB Holdings, Inc., a company known for its focus on biopharmaceuticals. His role at UCB has allowed him to leverage his expertise in developing therapies that target inflammatory diseases.

Collaborations

Throughout his career, Drouot has collaborated with esteemed colleagues, including Camil Sayegh and Nanqun Zhu. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Laurent Drouot's contributions to the field of medical treatment through his patent and work at UCB Holdings, Inc. highlight his dedication to advancing healthcare solutions. His innovative approach continues to inspire progress in the treatment of inflammatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…